Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016 Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …
News
ionis

Ionis achieves successful Phase 3 trial to treat rare diseases

December 19, 2016 Manufacturing and Production, Research and Development Akcea, Ionis, rare disease

Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …
News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016 Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …
News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016 Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …
News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …
Appointment
shutterstock_311949818

First human trial of tau-targeting Alzheimer’s vaccine shows promise

December 15, 2016 Medical Communications, Research and Development Alzheimer's

The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …
News

Pfizer’s next blockbuster given FDA approval

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
News
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
News
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …
News
dementia

Director and location of £250 million UK Dementia Research Institute revealed

December 14, 2016 Medical Communications, Research and Development Alzheimer’s Research UK, Medical Research Council, alzheimer's research uk, alzheimer's society

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …
News
ritalin-sr-20mg-1000x1000

35% of all imported medicine in Guyana is fake, investigation finds

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …
News
new_york

New York in $500 million de Blasio-backed biotech boost

December 14, 2016 Manufacturing and Production, Research and Development New York, biotech, funding

Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …
News
actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026